Registro:

Referencias:

• Battle, C., Porfirias y Porfirinas. Aspectos clínicos, bioquímicos y biología molecular (1997) Acta Bioquím. Clin. Latinoam., (SUPPL. NO.3), pp. 37-69. , Chapter II
• Batlle, A., Wider De Xifra, E., Stella, A.M., A simple method for measuring erythrocyte porphobilinogenase and its use in the diagnosis of acute intermittent porphyria (1978) Int. J. Biochem., 9, pp. 1-12
• Behne, M., Wilke, H.J., Harder, S., Clinical pharmacokinetics of sevoflurane (1999) Clin. Pharmacokinet., 36 (1), pp. 13-26
• Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding (1976) Anal. Biochem., 72, pp. 248-254
• Buzaleh, A.M., Enriquez De Salamanca, R., Batlle, A.M.D.C., Porphyrinogenic properties of the anesthetic enflurane (1992) Gen. Pharmac., 23, pp. 665-669
• Buzaleh, A.M., Enriquez De Salamanca, R., Batlle, A.M.D.C., Administration of the anesthetic Isoflurane to mice: A model for Acute Intermittent Porphyria? (1992) J. Pharmac. Methods., 28, pp. 191-197
• Buzaleh, A.M., Martínez, M.D.C., Batlle, A., The relevance of P-450 levels on enflurane and isoflurane action action in mice. Studies on heme pathway (2000) Clin. Exp. Pharmacol. Physiol., 27, pp. 796-800
• Buzaleh, A.M., García Bravo, M., Navarro, S., Morán Jimenez, M.J., Méndez, M., Batlle, A., Fontanellas, A., Enríquez De Salamanca, R., Volatile anaesthetics induce biochemical alterations in the heme pathway in a Blymphocyte cell line established from hepatoerythropoietic porphyria patients (LBHEP) and in mice inoculated with LBHEP cells (2004) Int. J. Biochem. Cell. Biol., 36, pp. 216-222
• Buzaleh, A.M., Morán-Jiménez, M.J., García-Bravo, M., Sampedro, A., Batlle, A., Enríquez De Salamanca, R., Fontanellas, A., Induction of Hepatic Aminolevulinate Acid Synthetase Activity by Isoflurane in a Genetic Model for Erythropoietic Protoporphyria (2009) Cell. Mol. Biol., 55, pp. 38-44
• Eger EI 2nd. New inhaled anesthetics. Review (1994) Anesthesiology, 80 (4), pp. 906-922
• Ellencweig, N., Schoenfeld, N., Zemishlany, Z., Acute Intermittent Porphyria: Psychosis as the only clinical manifestation (2006) Int. J. Psychiatry Relat. Sci., 43, pp. 52-56
• Fry, B.W., Ciardone, A.E., Fairclot, R.E., Early appearance of methoxyflurane fluor metabolites in mice (1980) Pharmacol. Ther. Dent., 5, pp. 79-86
• Goa, K.L., Noble, S., Spencer, C.M., Sevoflurane in Paediatric Anaesthesia. a Review (1999) Paediatric Drugs, 1, pp. 127-153
• Herrick, A.L., McColl, K.E.L., Acute intermittent porphyria (2005) Best Practice Res. Clin. Gastroenterol., 19, pp. 135-249
• Hoetzel, A., Geiger, S., Loop, T., Welle, A., Schmidt, R., Humar, M., Pahl, H.L., Pannen, B.H.J., Differential effects of volatile anesthetics on hepatic heme oxygenase - 1 Expression in the rat (2002) Anesthesiology, 97 (5), pp. 1318-1321. , DOI 10.1097/00000542-200211000-00043
• Jensen, N.F., Nd, F.D.S., Striepe, V., Anesthetic considerations in porphyrias (1995) Anesth. Analg., 80, pp. 591-599
• Kharasch, E.D., Thummel, K.E., Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane (1993) Anesthesiology, 79 (4), pp. 795-807
• Kharasch, E.D., Armstrong, A.S., Gunn, K., Artru, A., Cox, K., Karol, M.D., Clinical sevoflurane metabolism and disposition. II. the role of cytochrome P450 2E1 in fluoride and hexafluoroisopropanol formation (1995) Anesthesiology, 82 (6), pp. 1379-1388
• Lowry, O., Rosebrough, N., Farr, A., Randall, R., Protein measurement with the folin-phenol reagent (1951) J. Biol. Chem., 193, pp. 265-275
• Maines, M.D., Gibbs, P.E., 30 some years of heme oxygenase: From a "molecular wrecking ball" to a "mesmerizing" trigger of cellular events (2005) Biochem. Biophys. Res. Commun., 338, pp. 568-577
• Marver, H., Tschudy, D., Perlroth, M., Collins, A., δ- Aminolevulinic acid synthetase I. Studies in liver homogenates (1966) J. Biol. Chem., 241, pp. 2803-2809
• Omura, T., Sato, R., The carbon monoxide-binding pigment of liver microsomes. Evidence for its hemoprotein nature (1964) J. Biol. Chem., 239, pp. 2370-2378
• Parera, V.E., De Siervi, A., Varela, L., Rossetti, M.V., Batlle, A.M.D.C., Acute porphyrias in the Argentinean population: A Review (2003) Cell. Mol. Biol., 49, pp. 493-500
• Pantuck, E.J., Pantuck, C.B., Ryan, D.E., Conney, A.H., Inhibition and stimulation of Enflurane metabolism in the rat following a single dose of chronic administration of ethanol (1985) Anesthesiology, 62, pp. 255-262
• Patel, S.S., Goa, K.L., Sevoflurane: A Review of its Pharmacodynamic and Pharmacokinetic Properties and its Clinical Use in General Anaesthesia (1996) Drugs, 51 (4), pp. 658-700
• Poblete-Gutiérrez, P., Wiederholt, T., Merk, H.F., Frank, J., The Porphyrias: Clinical presentation, diagnosis and treatment (2006) Eur. J. Dermatol., 16, pp. 230-240
• Reinke, L.A., Moyer, M.J., A microsomal oxidation which is highly inducible by ethanol (1985) Drug Met. Disp., 13, pp. 548-552
• Sakai, E.M., Connolly, L.A., Klauck, J.A., Inhalation anesthesiology and volatile liquid anesthetics: Focus on isoflurane, desflurane, and sevoflurane (2005) Pharmacotherapy, 25 (12), pp. 1773-1788
• Sheppard, L., Dorman, T., Anesthesia in a child with homozygous porphobilinogen deaminase deficiency: A severe form of acute intermittent porphyria (2005) Paediatr. Anaesth., 15 (5), pp. 426-428
• Shimada, T., Mernaugh, R.L., Guengerich, F.P., Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5 enzymes (2005) Arch. Biochem. Biophys., 435, pp. 207-216
• Sigston, P.E., Jenkins, A.M., Jackson, E.A., Sury, M.R., Mackersie, A.M., Hatch, D.J., Rapid inhalation induction in children: 8% sevoflurane compared with 5% halothane (1997) Br. J. Anaesth., 78 (4), pp. 362-365
• Suematsu, M., COHb: A stress-induced marker reflecting surgical insults (2002) J. Gastroenterol. Hepatol., 17, pp. 519-520
• Tenhunen, R., Marver, H.S., Schmid, R., The enzymatic catabolism of hemoglobin: Stimulation of microsomal heme oxygenase by hemin (1970) J. Lab. Clin. Med., 75, pp. 410-421
• Thadani, H., Deacon, A., Peters, T., Diagnosis & management of porphyria (2000) B.M.J., 320, pp. 1647-1651
• Tomaro, M.L., Batlle, A.M.D.C., Bilirubin: Its role in cytoprotection against oxidative stress (2002) Int. J. Biochem. Cell Biol., 34, pp. 216-220
• Wallin, R.F., Regan, B.M., Napoli, M.D., Stern, I.J., Sevoflurane: A new inhalational anesthetic agent (1975) Anesth. Analg., 54, pp. 758-766
• Wandel, C., Neff, S., Kepppler, G., Bohrer, H., Stockinger, K., Wilkinson, G.R., Wood, M., Martin, E., The relationship between cytochrome P4502E1 activity and plasma fluoride levels after Sevoflurane anesthesia in humans (1997) Anesth. Analg., 85, pp. 924-930
• Young, C.J., Apfelbaum, J.L., Inhalational anesthetics desflurane and Sevoflurane (1995) J. Clin. Anesth., 7, pp. 564-577

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------